Cost–utility analysis conducted alongside randomized controlled trials: Are economic end points considered in sample size calculations and does it matter?

William Hollingworth(At Bristol), Chris Metcalfe(University of Bristol), Denise McKell-Redwood(University Hospitals Bristol NHS Foundation Trust), Lisa V. Hampson(Lancaster University)
Clinical Trials
December 11, 2012
Cited by 31


Related Papers